KDDF Global Biotech Showcase, Partnering Increased by 2.5 Times Compared to Last Year

[Financial News] The '2025 KDDF Global Biotech Showcase' of the National New Drug Development Institute (KDDF) concluded with the participation of the most investors ever. KDDF announced on the 29th that the event was held at the Fairmont Ambassador Seoul for two days from the 27th.
This year's event was prepared to expand global investment attraction and technology transfer opportunities for promising domestic new drug development companies and to strengthen the global competitiveness of the domestic bio ecosystem.
More than 380 people, including 67 prominent global and domestic investors, attended to actively explore new collaboration possibilities in new drug development through networking.
The one-on-one partnering meetings held over two days totaled 420, an increase of 2.5 times compared to last year. The institute facilitated efficient meetings between companies and investors using its own matching program, receiving evaluations that both the enthusiasm of participation and the depth of discussions were significantly enhanced.
In particular, the 'Round Table Meeting' introduced for the first time this year was conducted in a format where participants gathered around tables centered on key figures to freely exchange opinions. Opinions were actively shared from various perspectives on key industry topics such as investment, new drug development, AI/platform technology, and licensing/listing.
Noel Ji, a partner at Novo Holdings, who participated as a global venture capital investor in this event, said, "About four years ago, there were not many global investors paying attention to the Korean market, but recently I feel that global investors' interest in the Korean bio industry has increased."
He continued, "In particular, Korea has several strengths such as clinical trial environment and infrastructure, so investment and collaboration activities are expected to expand further in the next 2-3 years."
Youngmin Park, Director of KDDF, said, "I hope today's discussions will lead to tomorrow's cooperation and innovation," and added, "We will continue to provide various support so that domestic new drug development capabilities can be more recognized in the global market."
The institute plans to continue promoting various cooperation programs to expand the global network of domestic biotech and establish a sustainable growth foundation.

vrdw88@fnnews.com Kang Jungmo Reporter